1. Epigenetic Changes Induced by Infectious Agents in Cancer
   Fabiola E. Tristan-Flores et al, 2024, Pathogens Associated with the Development of Cancer in Humans CrossRef
2. The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA MALAT1 in cultured human hepatic carcinoma cells
   Hae In Choi et al, 2022, Scientific Reports CrossRef
3. Dynamic Interactions of Transcription Factors and Enhancer Reprogramming in Cancer Progression
   Emily Zboril et al, 2021, Frontiers in Oncology CrossRef
4. 3D epigenomics and 3D epigenopathies
   Kyung-Hwan Lee et al, 2024, BMB Reports CrossRef
5. ETS1 Function in Leukemia and Lymphoma
   Rebecca A. Luchtel, 2024, Transcription factors in blood cell development CrossRef
6. Oxadiazolines as Photoreleasable Labels for Drug Target Identification
   Corentin Bon et al, 2024, Journal of the American Chemical Society CrossRef
7. Understanding Immune Responses to Surgical Transplant Procedures in Stevens Johnsons Syndrome Patients
   Matias Soifer et al, 2021, Frontiers in Medicine CrossRef
8. Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein Inhibitors
   Peng-Hsun Chase Chen et al, 2024, ACS Central Science CrossRef
9. Commentary on: Xbp1s-Ddit3, DNA damage and pulmonary hypertension
   Sarah-Eve Lemay et al, 2022, Clinical Science CrossRef
10. Cadmium toxicity and autophagy: a review
    Yueting Shao et al, 2024, BioMetals CrossRef
11. Chemical Catalysis Guides Structural Identification for the Major In Vivo Metabolite of the BET Inhibitor JQ1
    Secondra Holmes et al, 2024, ACS Medicinal Chemistry Letters CrossRef
12. Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies
    Sophia A Wild et al, 2022, eLife CrossRef
13. BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes
    Li Ma et al, 2022, Cancer Biology & Therapy CrossRef